EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,757 | +17.5% | 3,474 | +27.9% | 0.00% | 0.0% |
| Q2 2023 | $23,629 | +214709.1% | 2,716 | -29.9% | 0.00% | – |
| Q1 2023 | $11 | 0.0% | 3,876 | +22.0% | 0.00% | – |
| Q4 2022 | $11 | -100.0% | 3,176 | -31.0% | 0.00% | -100.0% |
| Q3 2022 | $37,000 | +105.6% | 4,605 | +99.3% | 0.00% | – |
| Q2 2022 | $18,000 | -85.8% | 2,311 | -77.8% | 0.00% | -100.0% |
| Q1 2022 | $127,000 | +32.3% | 10,418 | +32.6% | 0.00% | -50.0% |
| Q4 2021 | $96,000 | +1271.4% | 7,856 | +1051.9% | 0.00% | – |
| Q3 2021 | $7,000 | -58.8% | 682 | -64.6% | 0.00% | – |
| Q2 2021 | $17,000 | -59.5% | 1,929 | -53.2% | 0.00% | -100.0% |
| Q1 2021 | $42,000 | +133.3% | 4,125 | +46.8% | 0.00% | 0.0% |
| Q4 2020 | $18,000 | – | 2,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |